In a landmark move for neuroscience and pain management, global biopharmaceutical powerhouse Eli Lilly has announced its acquisition of...
Read MoreIn a decisive move to fast-track innovation in cancer treatment, Lumanity and the Parker Institute for Cancer Immunotherapy (PICI)...
Read MoreIn a groundbreaking development for migraine and cluster headache sufferers, the US Food and Drug Administration (FDA) has approved...
Read MoreIn a bold step forward for women’s health, Sonrai Analytics and AOA Dx have announced a strategic partnership to...
Read MoreKaerus Bioscience has announced a significant milestone in its mission to tackle fragile X syndrome (FXS), with the U.S....
Read MoreAviadoBio has officially launched its Phase 1/2 ASPIRE-FTD clinical trial in the United Kingdom, marking a significant step forward...
Read More